| INSPIRE MEDICAL SYSTEMS |
| USA |
| Gesundheit |
| US4577301090 / A2JLEP |
| 2DR (Frankfurt) / INSP (NYSE) |
| FRA:2DR, ETR:2DR, 2DR:GR, NYSE:INSP |
| - |
| https://www.inspiresleep... |
|
Inspire Medical Systems, Inc. is a pioneering company focused on developing and commercializing innovative medical technology designed to treat obstructive sleep apnea (OSA). The company's flagship product, the Inspire therapy, is an implantable neur..
>Volltext.. |
| 1070.25 Mio. EUR |
| 850.42 Mio. EUR |
| 797.85 Mio. EUR |
| 58.71 Mio. EUR |
| 114.32 Mio. EUR |
| 3.94 EUR |
| 25.76 Mio. EUR |
| 86.24 Mio. EUR |
| 119.02 Mio. EUR |
| 3.17 |
| 2.01% |
| 84.63% |
| - |
| - |
| - |
| - |
| INSPIRE MEDICAL |
| 23.06.26 |
|